Tacrolimus: all 596 studies that test it
Page 6 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.
- TACrolimus in Renal Transplantation: Individualization by PharmacogeneticCompletedNCT00552201Phase 4
- Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen EncephalitisStatus unknownNCT00545493Phase 2/3
- Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver TransplantationCompletedNCT00538265Phase 4
- Tacrolimus Ointment Pharmacokinetics in Infants With Atopic DermatitisCompletedNCT00535691Phase 2
- Distribution of Tacrolimus in Skin, Atopic DermatitisCompletedNCT00534508Phase 2
- Interaction Between Rimonabant and Cyclosporine and TacrolimusCompletedNCT00525681Phase 4
- Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult PatientsCompletedNCT00523952Phase 3
- Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant PatientsCompletedNCT00519116Phase 4
- Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft RecipientsCompletedNCT00518271Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
- A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft FailureCompletedNCT00510913Phase 4
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on TacrolimusCompletedNCT00492661Phase 4
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney TransplantationCompletedNCT00481819Phase 3
- Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant SubjectsCompletedNCT00481481Phase 3
- Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentCompletedNCT00480896Phase 3
- Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentCompletedNCT00480610Phase 3
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidCompletedNCT00469131Phase 3
- Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
- Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating KeratoplastyTerminatedNCT00463723Phase 2/3
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver TransplantationCompletedNCT00459719Phase 3
- Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine InhibitorsCompletedNCT00456235Phase 4
- Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot StudyStatus unknownNCT00443105Phase 2
- Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
- Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyCompletedNCT00429377Phase 3
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver RecipientsCompletedNCT00384202Phase 3
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney RecipientsCompletedNCT00384137Phase 3
- Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisCompletedNCT00371319Phase 4
- Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis PatientsCompletedNCT00347048Phase 3
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerCompletedNCT00346359Phase 2
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT00337493Phase 4
- Pharmacokinetic Study on the Combination of Everolimus-TacrolimusStatus unknownNCT00325325Phase 2
- Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal GraftsCompletedNCT00321074Phase 3
- A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA PatientsCompletedNCT00319917Phase 4
- Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00317681Phase 2
- Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaCompletedNCT00313625Phase 2
- An Open Study for Steroid Resistant, Non-Thymectomized MG PatientsCompletedNCT00309101Phase 3
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) PatientsCompletedNCT00309088Phase 3
- Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family DonorStatus unknownNCT00304720Phase 2
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LNCompletedNCT00302549Not applicable
- Tacrolimus Treatment of Patients With Idiopathic Focal Segmental GlomerulosclerosisWithdrawnNCT00302536Not applicable
- Tacrolimus Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00302523Not applicable
- Combination Therapy of Betaseron-Prograf in Multiple SclerosisStatus unknownNCT00298662Phase 2
- Optimizing Prograf® Therapy in Renal Transplant PatientsCompletedNCT00297765Phase 4
- Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney TransplantationCompletedNCT00297310Phase 4
- To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.CompletedNCT00296361Phase 3
- Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.CompletedNCT00296309Phase 3
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.CompletedNCT00295594Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293930Phase 3
- A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293917Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293891Phase 3
- Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)Status unknownNCT00290069Phase 4
- The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant RecipientsCompletedNCT00275535Phase 4
- Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsCompletedNCT00261820Phase 4
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant RecipientsStatus unknownNCT00252655Phase 4
- Evaluation of Topical Antipsoriatics in the Psoriasis Plaque TestCompletedNCT00236171Not applicable
- Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney TransplantationStatus unknownNCT00204191Phase 4
- Comparison of Immunosuppression Protocols After LTx in ChildrenCompletedNCT00195988Phase 4
- A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney TransplantationCompletedNCT00189839Phase 3
- A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.CompletedNCT00189826Phase 3
- Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent AsthmaCompletedNCT00189787Phase 2
- A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT RecipientsCompletedNCT00189761Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-CompletedNCT00189748Phase 2
- Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent AsthmaCompletedNCT00189722Phase 2
- Pilot Trial for Implementation of a MPA PK Monitoring StrategyCompletedNCT00187915Not applicable
- The Vienna Prograf and Endothelial Progenitor Cell StudyCompletedNCT00182559Phase 4
- Effects of Ligands on Human Hair Follicles Grafted Onto SCID MiceCompletedNCT00177099Phase 1
- Sirolimus Blood Concentrations on Conversion From Oral Solution to TabletsStatus unknownNCT00166842Phase 4
- The Effect of Sirolimus on the Pharmacokinetics of TacrolimusStatus unknownNCT00166829Phase 4
- The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant PatientsStatus unknownNCT00166816Phase 4
- A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver TransplantationCompletedNCT00166556Phase 2
- Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant NephropathyCompletedNCT00160966Phase 4
- Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNCT00146614Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2
- Etanercept With Tacrolimus for PsoriasisCompletedNCT00134394Phase 2
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusCompletedNCT00133367Phase 2
- Effect of Rapid Steroid Withdrawal on Subclinical Markers of RejectionTerminatedNCT00133172Phase 4
- Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous NephritisCompletedNCT00125307Phase 4
- Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and EverolimusTerminatedNCT00117702Phase 2/3
- A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNCT00106496Phase 4
- Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00096096Phase 2
- Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00089037Phase 1/2
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid ArthritisCompletedNCT00036153Phase 3
- Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTerminatedNCT00034528Phase 2
- Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00028600Phase 2
- Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily DosingCompletedNCT00028171Not applicable
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00027573Phase 2
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaCompletedNCT00006747Phase 2
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006350Phase 2
- Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersCompletedNCT00003572Phase 2